Brittain Tyler J, Jang Seongmin, Coughlin Gerard M, Barcelona Bre'Anna H, Giriat Izabela, Ristic Fiona, Appling Nathan, Chossis Camille Pma, Shay Timothy F, Gradinaru Viviana
Division of Biology & Biological Engineering, California Institute of Technology, Pasadena CA 91125.
bioRxiv. 2025 Jun 3:2025.06.02.655683. doi: 10.1101/2025.06.02.655683.
Crossing the blood-brain barrier while minimizing liver transduction is a key challenge in developing safe adeno-associated virus (AAV) vectors for treating brain disorders. In mice, the engineered capsid PHP.eB shows enhanced brain transduction, while the further engineered CAP-B10 is also de-targeted from astrocytes and liver. Here, we solve cryo-EM structures of CAP-B10 and its complex with AAV receptor (AAVR) domain PKD2, at 2.22 and 2.20 Å resolutions, respectively. These structures reveal a structural motif that hinders AAVR binding, which we confirm by measuring affinities. We show that this motif is transferable to other capsids by solving cryo-EM structures of AAV9-X1 and AAV9-X1.1, without and with PKD2, at 3.09, 2.51, and 2.18 Å, respectively. Using this structural information, we designed and validated novel AAV variants with reduced liver and altered brain cell tropism . Overall, our findings demonstrate that rationally modulating AAVR affinity can alter liver targeting and cellular tropism.
在开发用于治疗脑部疾病的安全腺相关病毒(AAV)载体时,如何穿过血脑屏障同时尽量减少肝脏转导是一个关键挑战。在小鼠中,工程化衣壳PHP.eB显示出增强的脑部转导,而进一步工程化的CAP-B10也不再靶向星形胶质细胞和肝脏。在此,我们分别以2.22 Å和2.20 Å的分辨率解析了CAP-B10及其与AAV受体(AAVR)结构域PKD2的复合物的冷冻电镜结构。这些结构揭示了一个阻碍AAVR结合的结构基序,我们通过测量亲和力证实了这一点。我们通过分别以3.09 Å、2.51 Å和2.18 Å的分辨率解析有无PKD2时AAV9-X1和AAV9-X1.1的冷冻电镜结构,表明该基序可转移到其他衣壳。利用这些结构信息,我们设计并验证了具有降低肝脏靶向性和改变脑细胞嗜性的新型AAV变体。总体而言,我们的研究结果表明,合理调节AAVR亲和力可以改变肝脏靶向性和细胞嗜性。